$20M Gift to Boost Innovation in Health and Technology
December 8, 2022
By David Nutt
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology – ranging from precision, genomics-based medicine to the use of artificial intelligence and machine learning to improve clinical care.
Understanding Entrepreneurship Adds Value to Scientific Investigators’ Work and Enterprise Innovation Can Help
November 17, 2022
Dr. Nicholas Schiff, the Jerold B. Katz Professor of Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute, was among the early participants in entrepreneurship activity at Weill Cornell Medicine — even before the institution had the complete ecosystem that is Enterprise Innovation today.
Sixth Annual Symposium on Entrepreneurship and Academic Drug Development Highlights Expanding Entrepreneurial Ecosystem
November 17, 2022
When ophthalmologist Dr. John Pena was a first-year resident, he helped to treat a child with a form of cancer that originates in the back of the eye. Dr. Pena used advanced technology to see inside the eye’s clear, gel-like structure called the vitreous, and found abundant microscopic structures that transport biological information from one cell to another.
Weill Cornell Medicine Faculty and Trainees Participate in Conference Featuring Insightful Advice and Stories from Entrepreneurs
October 31, 2022
On Oct. 21, more than 300 Cornell and Weill Cornell Medicine faculty, students and alumni, as well as interested outsiders, joined the 2022 Eclectic Convergence Summit at Cornell Tech on Roosevelt Island. The daylong conference, sponsored by Entrepreneurship at Cornell, included talks from entrepreneurs, business executives and venture capitalists, as well as a pitch competition among business founders from Cornell’s Ithaca campus, Cornell Tech and Weill Cornell Medicine. The day’s talks spanned the gamut of biopharmaceuticals, women’s health, technology and social enterprises.
Center for Technology Licensing at Weill Cornell Addresses Health Inequity and Solutions
October 13, 2022
In celebration of diversity month, Enterprise Innovation’s CTL at Weill Cornell addressed disparities in health and health care affecting underrepresented groups in a special panel on Oct. 11 consisting of experts from academia, industry, government and investment.
Symposium Generates Momentum for Engineering Innovations in Medicine
October 12, 2022
More than 70 faculty from Weill Cornell Medicine, Cornell Engineering and Cornell Tech assembled in Ithaca — and more joined remotely — to kick off the Cornell Engineering Innovations in Medicine (CEIM) initiative.
BioVenture eLab kicked off Fall 2022 Accelerating BioVenture Innovation (ABI) program with special guest Dr. Gene Marcantonio, CEO of ARMGO Pharma, Inc.
August 31, 2022
On Aug. 30, the BioVenture eLab kicked off its Fall 2022 Accelerating BioVenture Innovation (ABI) program with an interview and Q&A with special guest Gene Marcantonio M.D., Ph.D., CEO of ARMGO Pharma, Inc.
Dr. Sheila Nirenberg Wins Barbara McClintock Women Innovator Award
June 17, 2022
Dr. Sheila Nirenberg, the Nanette Laitman Professor of Neurology and Neuroscience and a professor of physiology and biophysics at Weill Cornell Medicine, has received the Barbara McClintock Women Innovator Award at the Inaugural Women Innovator Awards.
2022 Biomedical Business Plan Challenge Showcases Promising Startups
June 3, 2022
A promising venture that hopes to develop a new drug therapy for colorectal cancer won $50,000 in funding and recognition from experienced venture capitalists on May 26 at the annual Biomedical Business Plan Challenge.
Weill Cornell Physicians Disseminate Imaging Standards Through Tech Ahead of Medicare Rule
May 6, 2022
A Weill Cornell Medicine collaboration between physicians and the Center for Technology Licensing (CTL) at Weill Cornell, part of the institution's Enterprise Innovation, is playing a unique role in disseminating standards for ordering diagnostic imaging ahead of a federal law that aims to rein in their overuse.